PDS Biotechnology Corporation

About PDS Biotechnology Corporation

PDS Biotech is a biotechnology company focused on transforming how the immune system targets and fights disease. Their mission is to create a new generation of targeted cancer treatments and infectious disease vaccines by harnessing the power of T cells. They aim to overcome tumors' ability to protect themselves from immune responses and induce potent tumor-infiltrating T cell attacks using proprietary targeted technologies.

Products & Services

Versamune® T Cell Activating Platform:A platform that trains the immune system to unleash a powerful targeted T cell attack, potentially improving treatment outcomes for cancer patients.

PDS01ADC and Versamune® Combination Platform:A combination platform that targets the tumor's internal environment to suppress its defenses against T cells while generating a potent T cell attack on cancer.

Immunotherapy Pipeline:A growing pipeline of immunotherapies targeting various cancers, including head and neck, prostate, breast, cervical, and other cancers, as well as infectious disease vaccines.

Specialties

Immunotherapy Cancer Treatment Infectious Disease Vaccines T Cell Activation Technology

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 11100000 MR: - FA: up to $11.1 million FAN: 11100000	D: 2025-11-11 FD: 2025-11-11	-
2	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 22000000 MR: - FA: up to $22 million FAN: 22000000	D: 2025-02-27 FD: 2025-02-27	2 investors
3	RT: Other (Sale of Net Operating Loss Tax Benefits) T: - FT: Other (Sale of Net Operating Loss Tax Benefits)	A: 1400000 MR: - FA: 1.4 million FAN: 1400000	D: 2023-04-24 FD: 2023-04-24	-

Registered Direct Offering Latest

2025-11-11

$11.1M

Registered Direct Offering 2025-02-27

$22.0M

Other (Sale of Net Operating Loss Tax Benefits) 2023-04-24

$1.4M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

I

Ilian Iliev

Director

G

Gregory Freitag

Director

O

Otis W. Brawley

Director

F

Frank Bedu-Addo

Chief Executive Officer, Director

K

Kamil Ali-Jackson

Director

S

Stephen Glover

Chairman

View 10 more team members with Pro

Unlock Full Team Directory

Recent News